NCT01356745

Brief Summary

Less than 10% of patients with a traumatic pain have been managed by a physician before to be admitted in an emergency service. 50 % of those patients have been carried by paramedics. Premixed nitrous oxide and oxygen is often used by paramedics, but no scientific studies have demonstrated its efficacy. The aim of the study is to demonstrate the efficacy of premixed nitrous oxide and oxygen in patients with out-of-hospital moderate acute pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Feb 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2010

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 19, 2011

Completed
Last Updated

May 12, 2017

Status Verified

May 1, 2017

Enrollment Period

1.2 years

First QC Date

June 22, 2010

Last Update Submit

May 10, 2017

Conditions

Keywords

premixed nitrous oxide and oxygenacute painprehospital setting

Outcome Measures

Primary Outcomes (1)

  • Number of patients with pain relief Number of patients with pain relief Number of patients with pain relief

    Pain is mesured with a numerical rating scale (NRS)score on 10.Pain relief is defined by a NRS score of 3 or less

    15 minutes

Secondary Outcomes (2)

  • Delay of analgesia (e.g. delay required to obtain analgesia)

    Every 5 minutes from randomization for a one hour period

  • Adverse events

    Every 5 minutes from randomization for a one hour period

Study Arms (2)

premixed 50% nitrous oxide and oxygen

EXPERIMENTAL
Drug: Premixed 50% nitrous oxide and oxygen (Kalinox)

medical air

PLACEBO COMPARATOR
Drug: medical air

Interventions

15 min inhalation dose (maximum duration of treatment of a subject)

premixed 50% nitrous oxide and oxygen

inhalation gas for inhalation use

medical air

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years old
  • Patients with a moderate acute pain (NRS score between 3 and 6)

You may not qualify if:

  • Contraindication of premixed 50% nitrous oxide and oxygen
  • Recent treatment of analgesic (less than 6 hours)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universty Hospital Toulouse SAMU 31

Toulouse, 31059, France

Location

Related Publications (1)

  • Ducasse JL, Siksik G, Durand-Bechu M, Couarraze S, Valle B, Lecoules N, Marco P, Lacombe T, Bounes V. Nitrous oxide for early analgesia in the emergency setting: a randomized, double-blind multicenter prehospital trial. Acad Emerg Med. 2013 Feb;20(2):178-84. doi: 10.1111/acem.12072.

MeSH Terms

Conditions

Acute Pain

Interventions

Nitrous OxideOxygenkalinoxAir

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen CompoundsChalcogensElementsAtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment and Public Health

Study Officials

  • Jean-Louis DUCASSE, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2010

First Posted

May 19, 2011

Study Start

February 1, 2010

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

May 12, 2017

Record last verified: 2017-05

Locations